Focus areas

Catering to four medical disciplines with specific needs

The focus of our work at medac is on improving established pharmaceutical products and diagnostics as well as developing new therapies in our four key areas rheumatology, urology, haematology, and oncology. We make essential treatments available worldwide – especially in fields of unmet therapeutic need.
Catering to four medical disciplines with specific needs

Rheumatology

Key rheumatological treatment improved

Rheumatic diseases imply a range of chronic treatment needs across a broad spectrum of patients. With the optimisation of a key treatment in this area, medac has succeeded in bringing a significant improvement to patients' quality of life.
Find out more Find out more
Key rheumatological treatment improved

Haematology

Innovative and life-saving treatment options

Haematology is a focus area of high importance for medac. To find new treatment approaches for rare diseases, medac addresses critical needs in haematology and has developed innovative products to improve the outcomes of stem cell transplantation.
Find out more Find out more
Innovative and life-saving treatment options

Oncology

Quality and innovation in supporting cancer care

Oncology has been a key focus and cornerstone of medac's success story throughout our corporate history. We have a strong, decades-long track record of reliable supply of medicinal products and supportive therapeutics across a range of oncological indications.
Find out more Find out more
Quality and innovation in supporting cancer care

Urology

Addressing unmet needs with urological therapies

Urology is a focus area of highest importance for medac. We have been active in this field from almost the very beginning of our company and are focused on developing a range of proprietary products that address a variety of unmet therapeutic needs.
Find out more Find out more
Addressing unmet needs with urological therapies

Reporting an adverse event

Apart from the desired effects, medical products can have side effects that are unpleasant or unintended. At medac, we continually collate information about side effects in order to monitor the benefit risk balance of each medication throughout its marketing lifecycle, and if necessary, can take action to better protect patient safety.

Reporting forms and information can be found at www.mhra.gov.uk/yellowcard. Adverse events should also be reported to medac Pharma at info@medacpharma.co.uk

We may contact you to gain further details about the report. However we are unable to provide medical advice. If you are concerned about any aspect of your treatment please discuss this with your healthcare professional (such as a doctor, nurse or pharmacist).

Lock

Login

Please enter your email address and password to log in.